Evidence map›Paper›PMID 37742660›Full record

ArticleJournal of Parkinson's disease2023

Burden of Parkinsonism and Parkinson's Disease on Health Service Use and Outcomes in Latin America.

Dani J Kim, Ana M Rodriguez-Salgado, Juan J Llibre-Rodriguez, Isaac Acosta, Ana Luisa Sosa, Daisy Acosta, Ivonne Z Jimenez-Velasquez, Mariella Guerra, Aquiles Salas, Christine Jeyachandran and 5 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of Parkinson's disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Genetic Variants in CytokinesLife (Basel, Switzerland) · 2025
    Article
  3. Barriers and Facilitators to Accessing Healthcare for People With Parkinson's Disease in Latin America: A Qualitative Study.Health expectations : an international journal of public participation in health care and health policy · 2025
    Article
  4. Article
  5. Article
  6. Tackling Parkinson's Disease as a Global Challenge.Journal of Parkinson's disease · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 13 institutions in 10 countries.

Dani J KimHealth Service and Population Research Department, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.
Ana M Rodriguez-SalgadoGlobal Brain Health Institute, University of San Francisco, San Francisco, CA, USA.
Juan J Llibre-RodriguezDementia Research Unit, Medical University of Havana, Havana, Cuba.
Isaac AcostaLaboratory of the Dementias, National Institute of Neurology and Neurosurgery, Mexico City, Mexico.
Ana Luisa SosaLaboratory of the Dementias, National Institute of Neurology and Neurosurgery, Mexico City, Mexico.
Daisy AcostaUniversidad Nacional Pedro Henriquez Ureña (UNPHU), Internal Medicine Department, Geriatric Section, Santo Domingo, Dominican Republic.
Ivonne Z Jimenez-VelasquezInternal Medicine Department, Geriatrics Program, School of Medicine, Medical Sciences Campus, University of Puerto Rico, San Juan, Puerto Rico.
Mariella GuerraInstituto de la Memoria Depresion y Enfermedades de Riesgo IMEDER, Lima, Perú.
Aquiles SalasMedicine Department, Caracas University Hospital, Faculty of Medicine, Universidad Central de Venezuela, Caracas, Venezuela.
Christine JeyachandranFaculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia.
Ricardo López-ContrerasMemory Clinic, Neurology Service, Salvadoran Social Security Institute, San Salvador, El Salvador.
Heike HesseObservatorio Covid-19, Universidad Tecnológica Centroamericana, Tegucigalpa, Honduras.
Caroline TannerDepartment of Neurology, Weill Institute for Neurosciences, University of California-San Francisco, San Francisco, CA, USA.
Jorge J Llibre-GuerraDepartment of Neurology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
Matthew PrinaPopulation Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Instituto Nacional de Neurología y Neurocirugía · MXCentral American Technological University · HNCentral University of Venezuela · VEGlobal Brain Health Institute · USInstituto de la Memoria Depresión y Enfermedades de Riesgo · PEKing's College London · GBNewcastle University · GBUniversidad Nacional Pedro Henríquez Ureña · DOUniversity of California, San Francisco · USUniversity of Havana · CUUniversity of Puerto Rico, Medical Sciences Campus · PRUNSW Sydney · AUWashington University in St. Louis · US

Funding

Understanding Alzheimer disease heterogeneity in Hispanic populations.K01AG073526 · NIA · WASHINGTON UNIVERSITY · PI Jorge Jesus Llibre-Guerra · 2022 to 2026
$511k
NIA NIH HHS K01 AG073526Wellcome Trust
6 · The paper itself

Abstract

backgroundLittle is known about the burden of parkinsonism and Parkinson's disease (PD) in Latin America. Better understanding of health service use and clinical outcomes in PD is needed to improve its prognosis.

objectiveThe aim of the study was to estimate the burden of parkinsonism and PD in six Latin American countries.

methods12,865 participants aged 65 years and older from the 10/66 population-based cohort study were analysed. Baseline assessments were conducted in 2003-2007 and followed-up 4 years later. Parkinsonism and PD were defined using current clinical criteria or self-reported diagnosis. Logistic regression models assessed the association between parkinsonism/PD with baseline health service use (community-based care or hospitalisation in the last 3 months) and Cox proportional hazards regression models with incident dependency (subjective assessment by interviewer based on informant interview) and mortality. Separate analyses for each country were combined via fixed effect meta-analysis.

resultsAt baseline, the prevalence of parkinsonism and PD was 7.9% (n = 934) and 2.6% (n = 317), respectively. Only parkinsonism was associated with hospital admission at baseline (OR 1.89, 95% CI 1.30-2.74). Among 7,296 participants without dependency at baseline, parkinsonism (HR 2.34, 95% CI 1.81-3.03) and PD (2.10, 1.37-3.24) were associated with incident dependency. Among 10,315 participants with vital status, parkinsonism (1.73, 1.50-1.99) and PD (1.38, 1.07-1.78) were associated with mortality. The Higgins I2 tests showed low to moderate levels of heterogeneity across countries.

conclusionsOur findings show that older people with parkinsonism or PD living in Latin America have higher risks of developing dependency and mortality but may have limited access to health services.

Indexed as

Parkinson DiseaseParkinsonian DisordersAgedCohort StudiesHumansLatin AmericaPatient Acceptance of Health Carehealth services administrationLatin AmericamortalityParkinsonian disorderspatient care

Identifiers

PMID37742660
PMCPMC10657702
OpenAlexW4386955396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.